ATE178096T1 - Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen - Google Patents
Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzenInfo
- Publication number
- ATE178096T1 ATE178096T1 AT92900907T AT92900907T ATE178096T1 AT E178096 T1 ATE178096 T1 AT E178096T1 AT 92900907 T AT92900907 T AT 92900907T AT 92900907 T AT92900907 T AT 92900907T AT E178096 T1 ATE178096 T1 AT E178096T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- monoclonal antibodies
- hepatitis
- antibodies against
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
- C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61017590A | 1990-11-07 | 1990-11-07 | |
| US64847391A | 1991-01-31 | 1991-01-31 | |
| US64847791A | 1991-01-31 | 1991-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE178096T1 true ATE178096T1 (de) | 1999-04-15 |
Family
ID=27417025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92900907T ATE178096T1 (de) | 1990-11-07 | 1991-11-07 | Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0556320B1 (de) |
| JP (3) | JP3242402B2 (de) |
| KR (1) | KR930702507A (de) |
| AT (1) | ATE178096T1 (de) |
| AU (1) | AU662503B2 (de) |
| CA (1) | CA2095735C (de) |
| DE (1) | DE69131046T2 (de) |
| DK (1) | DK0556320T3 (de) |
| ES (1) | ES2132115T3 (de) |
| GR (1) | GR3030212T3 (de) |
| TW (1) | TW206235B (de) |
| WO (1) | WO1992008738A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0569537T3 (da) * | 1991-01-31 | 1999-04-06 | Abbott Lab | Monoklonale antistoffer mod formodede HCV-kapperegioner og fremgangsmåder til anvendelse deraf |
| JP3217600B2 (ja) * | 1994-07-12 | 2001-10-09 | 株式会社先端生命科学研究所 | 非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ |
| DK0934526T3 (da) * | 1996-10-08 | 2003-05-05 | Bisys B V U | Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål |
| US6329157B1 (en) | 1998-05-28 | 2001-12-11 | Abbott Laboratories | Antigen cocktails and uses thereof |
| CA2316130A1 (en) * | 1999-08-19 | 2001-02-19 | Masanori Fukui | Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein |
| US20030232386A1 (en) * | 2002-06-17 | 2003-12-18 | Shah Dinesh O. | Assay conjugate and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486530A (en) * | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| AU624105B2 (en) * | 1987-11-18 | 1992-06-04 | Novartis Vaccines And Diagnostics, Inc. | Nanbv diagnostics and vaccines |
| EP0318216B2 (de) * | 1987-11-18 | 2001-08-29 | Chiron Corporation | NANBV-Diagnostika |
| US5124255A (en) | 1988-03-11 | 1992-06-23 | Abbott Laboratories | CKS method of protein synthesis |
| AU640620B2 (en) * | 1988-12-23 | 1993-09-02 | Neil Kenneth Robinson | Disabled persons wheelchair transfer sliding board |
| KR0185373B1 (ko) * | 1989-03-17 | 1999-05-01 | 로버트 피. 블랙버언 | Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용 |
| KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
| AU663064B2 (en) * | 1990-10-12 | 1995-09-28 | Abbott Laboratories | Hepatitis C virus antibody |
| US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
| ZA927837B (en) * | 1991-10-15 | 1994-03-11 | Akzo Nv | Monoclonal antibodiesto hepatitis C virus |
-
1991
- 1991-11-07 DE DE69131046T patent/DE69131046T2/de not_active Expired - Lifetime
- 1991-11-07 CA CA002095735A patent/CA2095735C/en not_active Expired - Lifetime
- 1991-11-07 EP EP92900907A patent/EP0556320B1/de not_active Expired - Lifetime
- 1991-11-07 KR KR1019930701354A patent/KR930702507A/ko not_active Withdrawn
- 1991-11-07 AU AU90777/91A patent/AU662503B2/en not_active Expired - Fee Related
- 1991-11-07 ES ES92900907T patent/ES2132115T3/es not_active Expired - Lifetime
- 1991-11-07 DK DK92900907T patent/DK0556320T3/da active
- 1991-11-07 WO PCT/US1991/008273 patent/WO1992008738A1/en not_active Ceased
- 1991-11-07 AT AT92900907T patent/ATE178096T1/de not_active IP Right Cessation
- 1991-11-07 JP JP50225692A patent/JP3242402B2/ja not_active Expired - Lifetime
- 1991-11-22 TW TW080109191A patent/TW206235B/zh active
-
1999
- 1999-05-13 GR GR990401297T patent/GR3030212T3/el unknown
-
2001
- 2001-04-19 JP JP2001120859A patent/JP3292727B2/ja not_active Expired - Lifetime
- 2001-04-19 JP JP2001120871A patent/JP3292728B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3292727B2 (ja) | 2002-06-17 |
| ES2132115T3 (es) | 1999-08-16 |
| JP2002012600A (ja) | 2002-01-15 |
| JPH06502076A (ja) | 1994-03-10 |
| TW206235B (de) | 1993-05-21 |
| WO1992008738A1 (en) | 1992-05-29 |
| GR3030212T3 (en) | 1999-08-31 |
| EP0556320A1 (de) | 1993-08-25 |
| KR930702507A (ko) | 1993-09-09 |
| JP3242402B2 (ja) | 2001-12-25 |
| AU662503B2 (en) | 1995-09-07 |
| EP0556320A4 (en) | 1994-11-23 |
| AU9077791A (en) | 1992-06-11 |
| DE69131046D1 (de) | 1999-04-29 |
| CA2095735A1 (en) | 1992-05-08 |
| DE69131046T2 (de) | 1999-10-21 |
| JP2002000267A (ja) | 2002-01-08 |
| CA2095735C (en) | 2004-02-03 |
| DK0556320T3 (da) | 1999-10-18 |
| JP3292728B2 (ja) | 2002-06-17 |
| EP0556320B1 (de) | 1999-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230146D1 (de) | Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung | |
| CA2469833A1 (en) | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them | |
| ATE171472T1 (de) | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 | |
| DE60231651D1 (de) | Proteinreinigungsverfahren | |
| FI942369A0 (fi) | Hepatitis-C-virustesti | |
| PT1308507E (pt) | Anticorpo monoclonal anti-núcleo de hcv | |
| DE69128273D1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
| DE60129278D1 (de) | Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen | |
| DE3789333D1 (de) | Menschlicher monoklonaler Antikörper gegen Lymphadenopathie assozierten Virus. | |
| ATE178096T1 (de) | Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen | |
| EA200200974A1 (ru) | Моноклональные антитела к рецептору лпнп человека, их получение и применение | |
| DK26587A (da) | Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette | |
| ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
| ATE167522T1 (de) | Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen | |
| DE69224134D1 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
| DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
| DE3884731D1 (de) | Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin. | |
| DE50212790D1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| DE3786090D1 (de) | Monoklonale antikoerper und verfahren zum nachweis von pathogenen pilzen. | |
| ATE294237T1 (de) | S?ugetier thymokingene | |
| ATE174060T1 (de) | Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden | |
| DE3787220D1 (de) | Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma. | |
| BR0204612A (pt) | Anticorpos monoclonais antinúcleo de hcv | |
| DE69331796D1 (de) | Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |